HIV-1 Specific T -Cells(Catherine Bollard)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameHIV-1 Specific T -Cells(Catherine Bollard)
Drug Alias NameHST-NEETs(Catherine Bollard)HIV-Specific T-cells With Non-escaped Epitope Targeting(Catherine Bollard)ex vivo expanded HIV-1 multi-antigen specific T-cell therapy(Catherine Bollard)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCatherine Bollard Children'S Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesCatherine Bollard Children'S Research Institute
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A